-
Je něco špatně v tomto záznamu ?
Neuropsychological Performance after Brain Arteriovenous Malformations Treatment
O. Bradac, A. Pulkrabkova, P. de Lacy, V. Benes,
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
PubMed
27835916
DOI
10.1055/s-0036-1592420
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- intrakraniální arteriovenózní malformace komplikace chirurgie MeSH
- kognitivní poruchy diagnóza etiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrochirurgie škodlivé účinky MeSH
- mladý dospělý MeSH
- neuropsychologické testy * MeSH
- retrospektivní studie MeSH
- terapeutická embolizace škodlivé účinky MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Background The treatment of brain arteriovenous malformations (AVMs) has been studied extensively. With the use of the Spetzler-Martin (S-M) grading system, patients can be informed appropriately about their possible surgical risks. This does not hold true for their neuropsychological sequelae, which have not been studied widely. We evaluated the neuropsychological outcome of our patients treated for brain AVMs. Methods Of 113 patients treated for a brain AVM between 2001 and 2009, 66 patients were enrolled in the study. All patients underwent treatment at our institution and neuropsychological testing 2 years later using a test battery constructed specifically for this study. A control group consisted of 10 subjects without any neurologic disease. Results When the whole cohort was analyzed, no significant differences were found between the groups distinguished by hemorrhage, gender, or hemispheric dominance. Patients with S-M IV and V scores fared significantly worse than patients with S-M I to III. Patients who presented with epilepsy scored lower than patients presenting with other symptomatology, but the difference had only borderline significance. When we analyzed patients according to the presence or absence of obliteration after treatment and compared these with the control group, we found no significant differences. When the patients with an obliterated AVM after treatment were subdivided according to treatment modality, there were no significant differences in their S-M groups compared with the control group. Similarly, those patients with nonobliterated AVMs analyzed according to their S-M grade showed a borderline significant difference, with S-M IV and V having a worse neuropsychological outcome compared with the other groups. Conclusions Patients harboring nonobliterated high-grade AVMs (S-M IV and V) scored worse than patients with nonobliterated AVM S-M grades I to III. This could be explained by the steal phenomenon. No differences in neuropsychological testing were found when comparing results according to nidus location. This study lends support to an active treatment policy for cerebral AVMs. Those patients in whom complete obliteration was achieved with treatment scored similarly to the background population, implying active AVM treatment does not cause deterioration in neuropsychological performance. This, together with a > 90% AVM obliteration rate, favors microsurgery as the treatment modality of choice whenever the AVM can be safely resected.
Department of Neurosurgery Royal Hallamshire Hospital Sheffield United Kingdom
Department of Psychology Military University Hospital Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016921
- 003
- CZ-PrNML
- 005
- 20180523132115.0
- 007
- ta
- 008
- 180515s2017 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1055/s-0036-1592420 $2 doi
- 035 __
- $a (PubMed)27835916
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Bradac, Ondrej $u Department of Neurosurgery and Neurooncology, Military University Hospital and Charles University, First Medical Faculty, Prague, Czech Republic.
- 245 10
- $a Neuropsychological Performance after Brain Arteriovenous Malformations Treatment / $c O. Bradac, A. Pulkrabkova, P. de Lacy, V. Benes,
- 520 9_
- $a Background The treatment of brain arteriovenous malformations (AVMs) has been studied extensively. With the use of the Spetzler-Martin (S-M) grading system, patients can be informed appropriately about their possible surgical risks. This does not hold true for their neuropsychological sequelae, which have not been studied widely. We evaluated the neuropsychological outcome of our patients treated for brain AVMs. Methods Of 113 patients treated for a brain AVM between 2001 and 2009, 66 patients were enrolled in the study. All patients underwent treatment at our institution and neuropsychological testing 2 years later using a test battery constructed specifically for this study. A control group consisted of 10 subjects without any neurologic disease. Results When the whole cohort was analyzed, no significant differences were found between the groups distinguished by hemorrhage, gender, or hemispheric dominance. Patients with S-M IV and V scores fared significantly worse than patients with S-M I to III. Patients who presented with epilepsy scored lower than patients presenting with other symptomatology, but the difference had only borderline significance. When we analyzed patients according to the presence or absence of obliteration after treatment and compared these with the control group, we found no significant differences. When the patients with an obliterated AVM after treatment were subdivided according to treatment modality, there were no significant differences in their S-M groups compared with the control group. Similarly, those patients with nonobliterated AVMs analyzed according to their S-M grade showed a borderline significant difference, with S-M IV and V having a worse neuropsychological outcome compared with the other groups. Conclusions Patients harboring nonobliterated high-grade AVMs (S-M IV and V) scored worse than patients with nonobliterated AVM S-M grades I to III. This could be explained by the steal phenomenon. No differences in neuropsychological testing were found when comparing results according to nidus location. This study lends support to an active treatment policy for cerebral AVMs. Those patients in whom complete obliteration was achieved with treatment scored similarly to the background population, implying active AVM treatment does not cause deterioration in neuropsychological performance. This, together with a > 90% AVM obliteration rate, favors microsurgery as the treatment modality of choice whenever the AVM can be safely resected.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a kognitivní poruchy $x diagnóza $x etiologie $7 D003072
- 650 _2
- $a terapeutická embolizace $x škodlivé účinky $7 D004621
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a intrakraniální arteriovenózní malformace $x komplikace $x chirurgie $7 D002538
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrochirurgie $x škodlivé účinky $7 D008866
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pulkrabkova, Alice $u Department of Psychology, Military University Hospital, Prague, Czech Republic.
- 700 1_
- $a de Lacy, Patricia $u Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield, United Kingdom.
- 700 1_
- $a Benes, Vladimir $u Department of Neurosurgery and Neurooncology, Military University Hospital and Charles University, First Medical Faculty, Prague, Czech Republic.
- 773 0_
- $w MED00179151 $t Journal of neurological surgery. Part A, Central European neurosurgery $x 2193-6323 $g Roč. 78, č. 4 (2017), s. 321-328
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27835916 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180523132259 $b ABA008
- 999 __
- $a ok $b bmc $g 1300545 $s 1013761
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 78 $c 4 $d 321-328 $e 20161111 $i 2193-6323 $m Journal of neurological surgery. Part A, Central European neurosurgery $n J Neurol Surg A Cent Eur Neurosurg $x MED00179151
- LZP __
- $a Pubmed-20180515